As the global demand for healthcare technologies accelerates, the Medical Devices Electronics Manufacturing Services (EMS) market is experiencing a renewed wave of growth, transformation, and consolidation. According to the latest QY Research report, the market is forecasted to grow from USD 15.1 billion in 2024 to USD 20.59 billion by 2031, driven by the increasing complexity of medical devices, rising demand for connected healthcare, and a global push toward efficient, scalable contract manufacturing.\n\nLeading Companies in the EMS Market • Foxconn • Luxshare • Pegatron • Quanta • Jabil • BYD Electronics • Sanmina • New KINPO • Wistron • Celestica • PLEXUS • Qisda Corporation • Zollner • Flex • Venture • Benchmark • USI\n\nFive leading companies and a key product\n\nFoxconn (Hon Hai Precision Industry Co.) • Product / Innovation: AI-powered nursing collaborative robot & digital-twin smart hospital platform • Key Data: Announced in May 2025 at GTC Taipei, Foxconn introduced a new generation of AI-assisted nursing robots capable of patient interaction, autonomous mobility, and real-time vital signs monitoring. It is part of a broader initiative to build digital-twin hospital systems, simulating patient flow, equipment usage, and diagnostics in a virtual environment to improve hospital efficiency and safety.\n\nFlex Ltd. • Product: Wearable patch pumps and blood glucose monitors • Key Data: Flex manufactures medical-grade wearable patch pumps and continuous glucose monitors through its automated EMS facilities, with ISO 13485-certified cleanroom environments. These devices are typically less than 60g in weight, support wireless data transmission, and achieve batch production volumes exceeding 5 million units annually across global facilities.\n\nSanmina Corporation • Product: Blood glucose meters and advanced diagnostic imaging devices • Key Data: Sanmina's EMS services cover Class II and III medical devices, including compact blood glucose meters (with ±10% accuracy range at 100 mg/dL) and large imaging systems like CT and ultrasound machines. The company provides design, engineering, and system integration for devices with production volumes ranging from 100 to 100,000+ units/year depending on complexity.\n\nJabil Inc. • Capability Highlight: Full-stack EMS for complex diagnostic and treatment devices • Key Data: As of mid-2025, Jabil employs over 138,000 people globally and generates approximately USD 28.9 billion in annual revenue. Its medical division supports integrated device development, including electronics miniaturization, embedded sensors, and data capture systems, handling high-mix, low-to-medium volume production for devices like infusion pumps and endoscopic controllers.\n\nCelestica Inc. • Operational Performance: High-reliability EMS for regulated healthcare devices • Key Data: Celestica's 2025 forecast shows an 11.7% year-over-year increase in total revenue and a 23.2% projected EPS growth, primarily driven by demand in the medical and aerospace segments. In its medical portfolio, the company manufactures diagnostic modules and control boards used in devices such as portable vital signs monitors and mobile X-ray systems.\n\nApplication Categories (as per Report) • Testing and Diagnosis • Treatment Equipment • Monitoring Equipment • Others\nService Type Categories (as per Report) • Electronic Manufacturing • Engineering Services • Test Development and Implementation • Logistics Services • Others\n\nEMS Market Trends and Industry Highlights in 2025\nThe global Medical Devices Electronics Manufacturing Services (EMS) market is entering a phase of sustained growth and strategic transformation, driven by demand from testing, diagnostic, monitoring, and treatment-related devices. In 2025, the industry continues to witness a shift towards miniaturization, automation, and regional production diversification.\n\nGrowth Anchored in Diagnostic and Monitoring Applications\nAccording to the newly released report \"Global Medical Devices Electronics Manufacturing Services (EMS) Market Outlook, In-Depth Analysis & Forecast to 2031\", diagnostic and monitoring applications are expected to dominate the downstream demand. Testing and Diagnosis segments were key revenue contributors in 2024, and are forecast to accelerate toward 2031, capturing a significant share of global EMS production. This aligns with rising demand for at-home diagnostics, wearable healthcare electronics, and AI-assisted monitoring systems.\n\nFoxconn, Jabil, and Flex Drive Technological Innovation in 2025\nIn the competitive landscape, Foxconn remains the market leader in 2025 by EMS revenue, leveraging its massive production capabilities and vertical integration strategy. The company expanded its medical segment footprint by incorporating smart testing modules into existing IoT platforms, a move aligned with regional demand in Southeast Asia and Europe. Meanwhile, Jabil continues its push into the medical sector with the 2025 launch of a new \"Advanced Medical Integration Center\" in North America, focusing on engineering services, compliance testing, and rapid prototyping for Class II and Class III medical devices. The facility is designed to reduce time-to-market for wearables and diagnostic equipment. Flex, another top EMS player, in 2025 introduced automated cleanroom assembly lines equipped with AI-powered optical inspection systems, improving yields for complex microelectronic medical components. Flex has reported a 12% productivity gain year-over-year in its Singapore facility, now fully dedicated to medical-grade contract assembly.\n\nShift Toward End-to-End EMS Models\nOne of the defining trends of 2025 is the increasing adoption of end-to-end EMS solutions—including design services, supply chain integration, testing, and post-sales support. OEMs are outsourcing not just assembly, but full product lifecycle services. According to the report, the EMS market's most promising segments include Engineering Services and Test Development & Implementation, which are growing faster than traditional assembly lines. Luxshare and Celestica have led in this space in 2025. Luxshare expanded its European operations to support EU-based OEMs navigating stricter regulatory regimes, while Celestica focused on expanding its design-for-manufacture capabilities with embedded traceability and software-driven quality validation platforms.\n\nRegional Dynamics and China's Strategic Dominance\nAsia-Pacific remains the largest and fastest-growing region for EMS in 2025. China's EMS sector, in particular, expanded its global share by aggressively investing in digital manufacturing capabilities and component self-sufficiency. China is forecast to remain the production hub through 2031, though rising labor and compliance costs are leading top manufacturers to expand into Southeast Asia. Japan and South Korea are also exhibiting strong CAGR figures, supported by local innovation in sensor technologies and battery solutions for wearable devices. Quanta and BYD Electronics are among the EMS firms scaling operations in these regions to serve growing domestic and international medical OEM demand.\n\nRegulatory and Compliance Shifts Affect Strategic Positioning\nIn 2025, regulatory compliance and intellectual property protection continue to influence EMS provider selection, particularly for high-risk medical devices. This has favored companies with ISO 13485 and FDA-compliant facilities. Sanmina and Benchmark Electronics have both expanded their FDA-approved cleanroom capacities in the U.S. and Mexico to capitalize on reshoring opportunities and mitigate supply chain risk. In addition, Zollner Elektronik AG reported a 15% increase in orders from European medtech startups in early 2025, citing demand for localized EMS providers familiar with EU MDR regulations.\n\nStrategic M&A and Capacity Expansion\n2025 is also marked by consolidation. Several mid-sized EMS companies are being acquired by larger players aiming to scale up medical sector penetration. Plexus and Venture have both announced strategic acquisitions in Southeast Asia aimed at strengthening their diagnostics and monitoring device production capabilities. Moreover, Qisda Corporation and USI have launched joint ventures focused on medical imaging module manufacturing, which could address a rising demand forecasted in the \"Treatment Equipment\" segment of the report.\n\nDownstream companies\n1. Medtronic\n2. Phillips\n3. Johnson & Johnson (J&J)\n4. StarFish Medical\n5. DnaNudge\n6. Smith+Nephew\n7. UFP Technologies (as EMS client for OEM devices)\n8. General Motors (through Jabil automotive segment, tangential usage)\n9. Boston Scientific\n10. Stryker\n11. Toshiba Medical Systems (Canon Medical)\n12. Siemens Healthineers\n13. Abbott Labs\n14. Olympus Corporation\n15. GE Healthcare

Global Medical Devices EMS Market to Hit USD 20.59 Billion by 2031 at 4.6% CAGR, Led by Foxconn and Jabil

The global Medical Devices Electronics Manufacturing Services (EMS) market is projected to grow from USD 15.1 billion in 2024 to USD 20.59 billion by 2031, at a compound annual growth rate (CAGR) of 4.6%. This growth is driven by increasing demand for connected healthcare, device miniaturization, automation, and regional production diversification. Key players including Foxconn, Jabil, Flex, Sanmina, and Celestica are leading innovation in AI-powered medical devices, wearable health monitors, and digital twin hospital platforms. The market is shifting toward end-to-end EMS solutions, with a strong focus on engineering services, testing, and compliance. Regional dynamics show Asia-Pacific as the largest and fastest-growing region, with China maintaining dominance in production. Regulatory compliance, particularly with ISO 13485 and FDA standards, is shaping strategic decisions. In 2025, several mid-sized EMS firms are undergoing strategic acquisitions or forming joint ventures to expand capacity in diagnostics and treatment equipment.